How to Ensure True Unidirectional Flow and Real First Air Protection on Design Phase

In aseptic processing, assumptions are risky. Undetected turbulence, suboptimal air distribution, or poorly protected critical zones can compromise product quality, regulatory compliance, and ultimately patient safety.

At Dara Pharma, these challenges are addressed by integrating advanced Computational Fluid Dynamics (CFD) simulations into the design of filling machines and advanced aseptic barriers.

Addressing Key Industry Challenges

Hidden airflow risks

Traditional design approaches may overlook micro-turbulence or dead zones. CFD enables visualization and early elimination of these risks.

Uncertain First Air Protection

Airflow paths are digitally validated to ensure critical areas receive continuous, uninterrupted sterile air.

Costly redesigns and delays

By simulating real conditions during the design phase, trial-and-error is minimized during construction and validation.

Regulatory pressure

This approach supports data-driven validation aligned with GMP expectations and Annex 1 requirements.

The Value This Brings to Your Operations

• Greater confidence in aseptic performance from day one
• Reduced risk of contamination and batch loss
• Faster project timelines with fewer on-site adjustments
• A robust foundation for regulatory compliance and audit readiness

By combining engineering expertise with digital simulation, Dara Pharma goes beyond building machines helping to de-risk aseptic processes.

CFD helps optimize performance and reduces time to FAT readiness by simplifying mock-ups and ergonomic tests.

Interested in learning how this approach can enhance your production?

Get in touch with our team to discuss your application and challenges.